EBI-907
EBI-907 is an orally active and highly potent B-RafV600E inhibitor. EBI-907 demonstrates excellent A375 and Colo-205 cellular antiproliferative activity with IC50 values of 13 nM and 14 nM, respectively. EBI-907 can also cause tumor regression in a B-RafV600E-dependent Colo-205 tumor xenograft model of mice. EBI-907 is promising for research of melanoma and B-RafV600E associated cancers[1][2].
Product Specifications
CAS Number
1581764-31-9
UNSPSC
12352005
Target
Raf
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ebi-907.html
Smiles
O=S(NC1=CC=C(C(C2=CC3=CNC4=NN=C(C5CC5)C4=C3C=C2OC)=C1Cl)F)(CCCF)=O
Molecular Formula
C23H21ClF2N4O3S
Molecular Weight
506.95
References & Citations
[1]Lu B, et al. Discovery of EBI-907: A highly potent and orally active B-Raf (V600E) inhibitor for the treatment of melanoma and associated cancers. Bioorg Med Chem Lett. 2016 Feb 1;26 (3) :819-823. |[2]Zhang J, et al. EBI-907, a novel BRAF (V600E) inhibitor, has potent oral anti-tumor activity and a broad kinase selectivity profile. Cancer Biol Ther. 2016;17 (2) :199-207.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![6,8-Dihydro-7H-pyrrolo[2,3-g]benzothiazol-7-one](https://cdn.genprice.uk/products/572/180789399718/imageurl/trc-d453658-25mg.webp)
TRC-D453658-25MG 25 mg
6,8-Dihydro-7H-pyrrolo[2,3-g]benzothiazol-7-one
Sign In for Pricing
View Details 
![LITAF Mouse Monoclonal Antibody [Clone ID: AT5C10]](https://cdn.genprice.uk/products/937/68dd189b061270361e8fc3f3/imageurl/am09081pu-n.webp)
AM09081PU-N 100 µL
LITAF Mouse Monoclonal Antibody [Clone ID: AT5C10]
Sign In for Pricing
View Details 